Article: SUN PHARMA AUGMENTS PRESENCE IN CONTROLLED SUBSTANCES.

Article: Sun Pharma.(News)(Sun Pharmaceutical ...
Chain Drug Review;  October 25, 2004 ;     680 words ...Sun Pharmaceutical Industries Ltd. of India is buying three drug brands from Women's First Healthcare. The Mumbai-based company is paying $5.4 million (U.S.) for Bactrim, Midrin and Ortho-Est.

Article: Sun Pharma's Equity Ownership of Caraco to Increase ...
PR Newswire;  February 3, 2004 ;     700+ words ... ... announced today that Sun Pharmaceutical Industries Limited ("Sun Pharma") has entered into an ... will ultimately increase Sun Pharma's and its affiliates ... this private transaction. Sun Pharma in its recent press release ...

Article: Sun Pharma's demerged research unit to list ...
PTI - The Press Trust of India Ltd.;  July 17, 2007 ;     432 words ... ... Mumbai, July 17 (PTI) - Sun Pharma Advanced Research Company, a demerged unit of Sun Pharma, will list its shares on ... of arrangement between Sun Pharmaceutical Industries Ltd and Sun Pharma Advanced Research Company ...

Article: Gujarat HC approves demerger of Sun Pharma's R&D ...
PTI - The Press Trust of India Ltd.;  March 30, 2007 ;     481 words ... ... Mar 30 (PTI) Drug maker Sun Pharma today said Gujarat High ... merge it with its subsidiary Sun Pharma Advanced Research Company ... as per the scheme, Sun Pharmaceutical Industries informed the BSE. Sun Pharma was planning to hive-off ...

Article: India: Taro Pharma quits merger deal with Sun ...
TendersInfo;  June 2, 2008 ;     617 words ... ... Sector Featured Israel Sun Pharma, India's largest pharmaceutical ... a subsidiary of Sun Pharmaceutical Industries Ltd. Last year, Sun Pharma had signed merger deal ... turnaround over the past year. Sun Pharma holds 34% stake in Taro ...

Article: SUN PHARMA REPORTS CONTINUING GROWTH IN Q3.
AsiaPulse News;  February 2, 2009 ;     700+ words ... ... RELEASE PR33340 Sun Pharma Reports Continuing ... by USFDA Sun Pharmaceutical Industries Ltd. (Reuters ... Top priority Sun Pharma continues to ... recession, Sun Pharma subsidiary, Caraco Pharmaceutical Industries, Ltd (NYSE ...

Article: Sun Pharma Reports Continuing Growth in Q3.
PR Newswire Europe;  January 30, 2009 ;     700+ words ... ... corresponding period last year. Sun Pharma holds 3.5% market share ... Generics - Top priority Sun Pharma continues to sell generic ... continuing economic recession, Sun Pharma subsidiary, Caraco Pharmaceutical Industries, Ltd (NYSE Alternext ...